LENTIGLOBIN Trademark

Trademark Overview

On Friday, June 30, 2017, a trademark application was filed for LENTIGLOBIN with the United States Patent and Trademark Office. The USPTO has given the LENTIGLOBIN trademark a serial number of 79228010. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, November 14, 2025. This trademark is owned by Bluebird Bio (UK) Ltd.. The LENTIGLOBIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of genetic diseases
lentiglobin

General Information

Serial Number79228010
Word MarkLENTIGLOBIN
Filing DateFriday, June 30, 2017
Status709 - CANCELLED - SECTION 71
Status DateFriday, November 14, 2025
Registration Number5736038
Registration DateTuesday, April 30, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 12, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of genetic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, November 14, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenetix Biotherapeutics, Inc.
Party Type31 - New Owner After Registration
Legal Entity Type98 - Unknown
AddressUS
Party Namebluebird bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressUS
Party NameBLUEBIRD BIO, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge MA 02142
US
Party NameBLUEBIRD BIO, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressCambridge MA 02142
US
Party NameBluebird Bio (UK) Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events

Event DateEvent Description
Thursday, March 1, 2018SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Tuesday, March 6, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 6, 2018ASSIGNED TO EXAMINER
Saturday, March 10, 2018APPLICATION FILING RECEIPT MAILED
Monday, March 12, 2018NON-FINAL ACTION WRITTEN
Tuesday, March 13, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 20, 2018REFUSAL PROCESSED BY MPU
Tuesday, March 20, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 27, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 27, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 6, 2018REFUSAL PROCESSED BY IB
Thursday, September 20, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 20, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 20, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 25, 2018SUSPENSION LETTER WRITTEN
Tuesday, September 25, 2018LETTER OF SUSPENSION E-MAILED
Tuesday, September 25, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, November 8, 2018CHANGE OF OWNER RECEIVED FROM IB
Tuesday, December 4, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 7, 2018ASSIGNED TO LIE
Thursday, December 13, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 13, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 20, 2018EXAMINERS AMENDMENT -WRITTEN
Thursday, December 20, 2018EXAMINERS AMENDMENT E-MAILED
Thursday, December 20, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 20, 2018EXAMINER'S AMENDMENT ENTERED
Monday, January 7, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 9, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 23, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, January 23, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 23, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, February 8, 2019NOTIFICATION PROCESSED BY IB
Tuesday, February 12, 2019PUBLISHED FOR OPPOSITION
Tuesday, February 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 30, 2019REGISTERED-PRINCIPAL REGISTER
Monday, May 13, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 30, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, August 24, 2019FINAL DISPOSITION PROCESSED
Saturday, August 24, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, September 13, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, October 18, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 15, 2019NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 26, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, September 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, December 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, April 30, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, June 15, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 13, 2024NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 25, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 25, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 25, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 25, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 25, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 13, 2025NEW REPRESENTATIVE AT IB RECEIVED
Friday, November 14, 2025CANCELLED SECTION 71
Thursday, December 18, 2025CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

lentiglobin genetic diseases treatment substances preparations pharmaceutical